Logo

Boehringer Ingelheim discontinues development of BI 1467335 for Diabetic Retinopathy

Share this
Boehringer Ingelheim discontinues development of BI 1467335 for Diabetic Retinopathy

Boehringer Ingelheim discontinues development of BI 1467335 for Diabetic Retinopathy

Share this article on WhatsApp, LinkedIn and Twitter



Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions